Symposium Presidents' Awards for Scientific Excellence

The following poster presentations from our 2002 symposium have received the Symposium Presidents' Award for Scientific Excellence.

Saturday, February 9

Session	Title	Presenter
Chromosomal Aberrations Honorable Mention	Disruption of the RanBP17/Hox11L2 region by recombination with the TCR delta locus in acute lymphoblastic leukemias with t(5;14)(q34;q11).	JWG Janssen, PhD
Gene Expression, Part 1 Winner	Peptide mimotopes of Tumor Associated Carbohydrate Antigens mediate anti-tumor cellular responses.	T Kieber-Emmons
Gene Expression, Part 1 Honorable Mention	Methylation status of E-cadherin gene and its correlation to histological grade of malignancy in adenoid cystic carcinoma	S Maruya, MD
Gene Therapy, Part 1 Winner	The role of PTEN gene therapy in bladder cancer	HB Grossman, MD
Gene Therapy, Part 1 Honorable Mention	Restoration of an impaired TGF-β1 autocrine growth-inhibitory circuit using a gene transfer approach results in growth inhibition of some epithelial cancer cell lines.	Z Zeinoun, MS
Chromatin Structures Honorable Mention	Prognostic value of single micrometastatic cells detected in bone marrow of prostate cancer patients	D Weckermann, MD
Viral Oncogenesis Winner	Distribution of high-risk HPV types in Yugoslav women with cervical neoplasm	Z Magic, MD, PhD

Sunday, February 10

Session	Title	Presenter
Carcinogenesis Winner	Mucinous carcinoma of the colon in TGFβ1-deficient mice	T Doetschman, PhD
Carcinogenesis Honorable Mention	Analysis of gastric mutations frequency induced by Helicobacter pylori during long term chronic infection in mice.	E Touati
Metastasis Winner	Cleavage of activated leukocyte cell adhesion molecule: a gateway to melanoma metastasis?	GWM Swart, PhD
Metastasis Honorable Mention	Tissue factor expression in human colorectal carcinoma: correlation with hepatic metastasis	S Seto, MD
Risk Assessment, Part 1 Winner	Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 carriers.	P Ghadirian, PhD
Risk Assessment, Part 1 Honorable Mention	BRCA2 and genetic instability	VP Yu, MA,MB, PhD
Apoptosis - Molecular Mechanisms Winner	Apoptosis in HEP2 cells treated with etoposide and colchicine	E Rudolf
Apoptosis - Molecular Mechanisms Honorable Mention	G-CSF withdrawal-induced apoptosis of neutrophils following systemic chemotherapy for patients with recurrent breast cancer	Y Ogawa, MD, PhD
Apoptosis - Molecular Mechanisms Honorable Mention	Autocrine signaling through Ras regulates cell survival activity in human glioma cells: a potential crosstalk between Ras and PI3K-Akt pathway	K Sakata, MD
Prevention Honorable Mention	Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinomas	S Zhong, PhD
Prevention Honorable Mention	Inhibition of tumor cell invasion by the a3 chain of type IV collagen	S Pasco, PhD
Dietary Influences Honorable Mention	Solution structure of the 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine (PhIP)-C8-dG adduct opposite dC in a DNA duplex	BE Hingerty, PhD

Monday, February 11

Session	Title	Presenter
Angiogenesis Winner	Anaplastic and differentiated thyroid carcinoma express different profiles of angiogenic stimuli and inhibitors	GL Francis, MD PhD
Gene Therapy, Part 2 Honorable Mention	IN VIVO targeted transfection of IL-3 gene into murine haematopoietic progenitor cells through CD117	A Chapel
Familial and Hereditary Cancer Winner	Preventive genetic screening for detection of inherited medullary thyroid carcinoma (MTC): outcome of the five years program	M Wiench, PhD
Environment and Occupation Honorable Mention	Common genetic variants of TP53 and BRCA2 in esophageal cancer patients and healthy individuals from low and high risk areas of northern China	PR Taylor, MD, ScD
Environment and Occupation Honorable Mention	Evaluation of potential genotoxic effects of three drinking water disinfectants using plant tests.	C Zani
Gene Expression, Part 2 Honorable Mention	Differential gene expression in estrogen receptor negative breast cancer cells transfected with cDNA for estrogen receptor	N Ros, MSc
Novel Therapies, Part 1 Honorable Mention	Novel Drug Resistance-associated Protein and new plant derived modulators for overcoming drug resistance in human tumor cells	C Ramachandran, PhD
Novel Therapies, Part 1 Winner	The tyrosine kinase inhibitor sti571 downregulates gene expression by reducing histone h4 acetylation and histone deacetylase (hdac) expression.	G Brusa, PhD
Novel Therapies, Part 1 Honorable Mention	Prevention of radiation-induced pulmonary fibrosis by blockade of transforming growth factor-beta (TGF-β) signaling	A Nishioka, MD
Predictive Markers Winner	Expression of human Telomerase Reverse Transcriptase (hTERT) mRNA in tumor cells from urine, as tumor marker for monitoring both relapse and urothelial microdissemination in bladder carcinoma	E Caso, MD, PhD
Predictive Markers Honorable Mention	Clinical impact of circulating tumor cells (CTC) morphological and molecular (β catenin mutations) characterization in patients with hepatocellular carcinoma	P Paterlini-Brechot
Predictive Markers Honorable Mention	Microvascular Changes During Inhibition of Colorectal Liver Metastases by SMANCS/Lipiodol.	D Kuruppu, PhD

Tuesday, February 12

Session	Title	Presenter
Diagnostic Markers Honorable Mention	A rapid FISH diagnosis of Ph (+) acute lymphoblastic leukemia on bone marrow and peripheral blood smears	A Gaworczyk, MD
Diagnostic Markers Honorable Mention	The hKLK3 gene coding for the tumour marker PSA (Prostate-specific antigen) is a multiply spliced gene.	Y Courty, PhD
Autoimmunity Honorable Mention	Regulatory CD8⁺ T cells control autoreactive CD4⁺ clones in healthy subjects	M Molteni, PhD
Stem Cell Biology Honorable Mention	Bone marrow homing heptapeptide bears homology to CD84	PS Becker, MD, PhD
Prognostic Markers Winner	Reliability assessment of soluble c-erbB-2 concentrations in the saliva of healthy women and men.	CF Streckfus, DDS
Prognostic Markers Honorable Mention	Proteomic analysis of beta-catenin during the neoplastic progression from precursor lesions to invasive squamous cell carcinoma of the esophagus	M Roth, MD
Prognostic Markers Honorable Mention	Mutational alterations of connexin 43 associated with advanced stage of progression of human colon cancer	VA Krutovskikh, MD PhD
Immunotherapy Honorable Mention	Anti-idiotypic antibodies induced by genetic immunization are directed exclusively against combined V_L/V_H determinants: implications on the mechanism of protection	M Cesco-Gaspere
Novel Therapies, Part 2 Winner	Survival of colorectal cancer patients with high levels of sialyl lewis-x and sialyl lewis-a epitope expression on tumor cells was improved by cimetidine	S Matsumoto, MD, PhD